Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C DE LANGE

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
White paper: landscape on technical and conceptual requirements and competence framework in drug/disease modeling and simulationG Vlasakakis, E Comets, A Keunecke, et al.
Endocrinology|April 7, 1998
Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout miceO C Meijer, E C de Lange, D D Breimer, et al.
Human Brain Mapping|December 4, 2021
Statistical testing in transcriptomic-neuroimaging studies: A how-to and evaluation of methods assessing spatial and gene specificityYongbin Wei, Siemon C de Lange, Rory Pijnenburg, et al.
Neuroimage|May 26, 2011
Simultaneous in vivo measurements of receptor density and affinity using [11C]flumazenil and positron emission tomography: comparison of full saturation and steady state methodsStina Syvänen, Elizabeth C de Lange, Yoshihiko Tagawa, et al.
Schizophrenia Bulletin|March 31, 2019
Connectome-Based Patterns of First-Episode Medication-Naïve Patients With SchizophreniaLong-Biao Cui, Yongbin Wei, Yi-Bin Xi, et al.
BMC Medical Imaging|January 5, 2011
(R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticusStina Syvänen, Gert Luurtsema, Carla F M Molthoff, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 30, 2026
Surgeon's treatment outcome prediction: accuracy and communicationLisa Vlug, Ellen C de Lange, Anouk A Kruiswijk, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2000
In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacinE C de Lange, S Marchand, D van den Berg, et al.
Neuropharmacology|June 1, 2014
(R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy modelRenée Marie Bogdanović, Stina Syvänen, Christina Michler, et al.
Endocrinology|May 18, 2001
Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brainA M Karssen, O C Meijer, I C van der Sandt, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
White paper: landscape on technical and conceptual requirements and competence framework in drug/disease modeling and simulationG Vlasakakis, E Comets, A Keunecke, et al.
Endocrinology|April 7, 1998
Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout miceO C Meijer, E C de Lange, D D Breimer, et al.
Human Brain Mapping|December 4, 2021
Statistical testing in transcriptomic-neuroimaging studies: A how-to and evaluation of methods assessing spatial and gene specificityYongbin Wei, Siemon C de Lange, Rory Pijnenburg, et al.
Neuroimage|May 26, 2011
Simultaneous in vivo measurements of receptor density and affinity using [11C]flumazenil and positron emission tomography: comparison of full saturation and steady state methodsStina Syvänen, Elizabeth C de Lange, Yoshihiko Tagawa, et al.
Schizophrenia Bulletin|March 31, 2019
Connectome-Based Patterns of First-Episode Medication-Naïve Patients With SchizophreniaLong-Biao Cui, Yongbin Wei, Yi-Bin Xi, et al.
BMC Medical Imaging|January 5, 2011
(R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticusStina Syvänen, Gert Luurtsema, Carla F M Molthoff, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 30, 2026
Surgeon's treatment outcome prediction: accuracy and communicationLisa Vlug, Ellen C de Lange, Anouk A Kruiswijk, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2000
In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacinE C de Lange, S Marchand, D van den Berg, et al.
Neuropharmacology|June 1, 2014
(R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy modelRenée Marie Bogdanović, Stina Syvänen, Christina Michler, et al.
Endocrinology|May 18, 2001
Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brainA M Karssen, O C Meijer, I C van der Sandt, et al.
Pageof 10